In particular, we found that in hypoxic cells, the induction of miR-675-5p endorsed β-catenin nuclear localization by affecting GSK3β activity, thus identifying in the miR-675-5p, a putative therapeutic target to inhibit aggressive CRC. The gene discussed is GSK3B; the disease is colorectal carcinoma.